Close X
Sunday, October 6, 2024
ADVT 
National

B.C. company expands antibody research, production facilities for second time

Darpan News Desk The Canadian Press, 24 May, 2023 03:30 PM
  • B.C. company expands antibody research, production facilities for second time

A Vancouver-based company that helped develop the first antibody therapy treatment for COVID-19 is expanding its research and development capacity as it continues to pursue world-leading new medicines, says Innovation Minister Francois-Philippe Champagne.

AbCellera Biologics announced a $701-million federal and British Columbia-backed infrastructure project Wednesday that will increase the overall scope of a manufacturing plant, which has been in the works since 2020, to facilitate clinical trials and help deliver antibody medicines to patients.

The federal government gave AbCellera $176 million toward the manufacturing plant and announced another $225 million Wednesday for the research and clinical trial projects, Champagne told a news conference at AbCellera's headquarters.

The B.C. government is providing $75 million.

"We're building a global champion," Champagne said. "I think (of) this morning as one of the historic moments where we build a Canadian champion that we can all be proud of as Canadians."

AbCellera senior vice-president Murray McCutcheon said the company's expansion project, which is described as a biotech campus, will be able to take research on antibody therapies from early ideas through to clinical trials.

Vaccines trigger the body to make antibodies to prevent or limit an infection before exposure, and antibody therapies are given to help a body fight off an infection after it has already started.

AbCellera partnered with drug giant Eli Lilly in 2020 to develop Bamlanivimab, which was authorized for use less than a year after the first case of COVID-19 was discovered.

While AbCellera helped discover that therapy, the doses were manufactured outside of Canada.

The new manufacturing plant is under construction now and is set to be producing antibody therapies for clinical trials starting next year.

B.C. Premier David Eby said the expansion project will create more than 400 jobs, while ensuring world-leading medicines are developed in Canada for Canadians and people globally.

"This means new training for British Columbians, this investment today," he said. "It means access to frontline treatment through clinical trials. It means that when intellectual property is developed through research here that the financial benefits stay in our province and in our country."

The expansion of the medical research also means if there is another global pandemic "we have the capacity here in our province and our country to support Canadians and British Columbians," Eby said.

McCutcheon said the first focus will be on antibody therapies for use against cancer and autoimmune diseases.

The company was founded in 2012 and currently has about 500 employees.

MORE National ARTICLES

Surrey, B.C., municipal police force calls for clarity over future

Surrey, B.C., municipal police force calls for clarity over future
An open letter from the Surrey Police Service says the ongoing debate over whether the city transitions to using a municipal force or returns to the RCMP means employees are increasingly distracted by worries about their futures. The letter calls for "a clear and safe path forward for policing in Surrey."

Surrey, B.C., municipal police force calls for clarity over future

Driver strikes a pole in 152nd Street area of Surrey, road closures in effect

Driver strikes a pole in 152nd Street area of Surrey, road closures in effect
Surrey RCMP is investigating a single vehicle collision in the area of 152nd street and 62a Avenue. A vehicle was travelling north bound on 152 street when the driver lost control and struck a power pole, severely damaging it.

Driver strikes a pole in 152nd Street area of Surrey, road closures in effect

Surrey RCMP need the public's help in locating missing man Parmjit Dhillon

Surrey RCMP need the public's help in locating missing man Parmjit Dhillon
Parmjit was driving a 2007 white Honda Civic bearing British Columbia, license plate “595GMV”.  Parmjit is described as a South Asian male, 5’7”, 146 lbs, short white hair, brown eyes; wearing a black jacket.   

Surrey RCMP need the public's help in locating missing man Parmjit Dhillon

Cyclist struck in Maple Ridge

Cyclist struck in Maple Ridge
Ridge Meadows RCMP frontline members were first on scene and with support from BC Emergency Health Services (BCEHS) assessed that the cyclist suffered serious but non-life-threatening injuries. The cyclist was transported to hospital.

Cyclist struck in Maple Ridge

Johnston advises against inquiry, but aims to hold hearings on foreign interference

Johnston advises against inquiry, but aims to hold hearings on foreign interference
The former governor general said an inquiry cannot be undertaken in public because of the sensitivity of the intelligence involved, and there would be considerable overlap with the work that he has already been doing to investigate the issue of alleged foreign meddling in the last two federal elections. 

Johnston advises against inquiry, but aims to hold hearings on foreign interference

Federal government pledges $5M to Chinese Canadian Museum in Vancouver

Federal government pledges $5M to Chinese Canadian Museum in Vancouver
The museum will feature an exhibition titled "The Paper Trail to the 1923 Chinese Exclusion Act," with the July 1 opening date coinciding with the centennial of the passing of the act which effectively halted all immigration from China.

Federal government pledges $5M to Chinese Canadian Museum in Vancouver

PrevNext